HCA Holdings Inc. Stock
Price
Target price
€324.20
€324.20
0.970%
3.1
0.970%
€359.19
17.06.25 / Tradegate
WKN: A1JFMW / Symbol: HCA / Name: HCA Holdings / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
HCA Holdings Inc. Stock
HCA Holdings Inc. gained 0.970% compared to yesterday.
The stock is one of the favorites of our community with 30 Buy predictions and 1 Sell predictions.
As a result the target price of 359 € shows a slightly positive potential of 10.73% compared to the current price of 324.2 € for HCA Holdings Inc..
Pros and Cons of HCA Holdings Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of HCA Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| HCA Holdings Inc. | 0.970% | 1.503% | -6.786% | 3.678% | 12.883% | 94.972% | 254.201% |
| Anthem Inc. | 0.180% | -2.798% | -9.704% | -34.418% | -7.269% | -22.872% | 38.185% |
| Quest Diagnostics Inc. | -1.170% | 0.322% | -2.350% | 22.044% | 7.557% | 28.610% | 55.850% |
| Universal Health Services B | -0.680% | -1.316% | -15.730% | -15.254% | -12.281% | 51.622% | 68.539% |
Comments
HCA Healthcare, Inc. (NYSE: HCA) was upgraded by analysts at Stephens to a "strong-buy" rating.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Barclays PLC from $366.00 to $416.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $384.00 to $376.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat